ATHE SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Aug 28, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Aug 28, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Sep 26, 2024

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Aug 31, 2023

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Aug 31, 2022

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Sep 2, 2021

News

TYPE

HEADLINE

FILED AT

6-K

Alterity Therapeutics Releases Q1 FY27 Quarterly Cash Flow Report and Provides Corporate Update on ATH434 Development

Oct 30, 2026

6-K

Alterity Therapeutics Limited Submits Form 6-K Regarding Proposed Issue of Securities

Oct 23, 2026

6-K

Alterity Therapeutics Limited Submits Form 6-K Including Notification Regarding Unquoted Securities

Oct 23, 2026

6-K

SEC Filing Exhibit 99.1 Notice

Oct 23, 2026

6-K

Alterity Therapeutics Submits Notice of Annual General Meeting/Proxy Form

Oct 21, 2026

6-K

Alterity Therapeutics Announces Changes to CEO and Managing Director Remuneration

Oct 21, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Feb 15, 2024

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Jan 6, 2021

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Dec 16, 2020

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Nov 23, 2020

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

May 22, 2019

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Apr 10, 2019

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Sep 18, 2026

F-3

Form F-3 - Registration statement by foreign private issuers

Oct 2, 2023

F-3

Form F-3 - Registration statement by foreign private issuers

Dec 23, 2020

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Dec 2, 2020

F-3

Form F-3 - Registration statement by foreign private issuers

Nov 13, 2020

F-3

Form F-3 - Registration statement by foreign private issuers

Oct 5, 2020

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Marks Peter Ashley (Reporting)

Sep 8, 2026

Stamler David Allen (Reporting)

Sep 8, 2026

Babarczy Julian Michael (Reporting)

Jun 23, 2026

Gozlan Lawrence Bernard (Reporting)

Jun 23, 2026

Cunningham Ann Michelle (Reporting)

Apr 29, 2026

Stamler David Allen (Reporting)

Apr 15, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Oct 26, 2023

CORRESP

Form CORRESP - Correspondence

Oct 23, 2023

LETTER

Form UPLOAD - SEC-generated letter

Oct 12, 2023

EFFECT

Form EFFECT - Notice of Effectiveness

Jan 7, 2021

CORRESP

Form CORRESP - Correspondence

Jan 4, 2021

LETTER

Form UPLOAD - SEC-generated letter

Dec 29, 2020

Alterity Therapeutics Limited ATHE · SEC Filings